source
- CTAD 2026: Biogen, AriBio lead the way in slowing cognitive decline in Alzheimer’sBiogen and AriBio reported wins for their respective therapies targeting Alzheimer’s disease, while Priavoid and Cognito Therapeutics missed the mark—though the latter plans to file for FDA approva…BioSpace · 1d ago↗ source
- Crown Biosciences stays put as $204M Adicon deal falls throughCrown Biosciences looks destined to go unworn for a while longer after its planned $204 million acquisition by China's Adicon fell through.Fierce Biotech · 1d ago↗ source
- FDA Approves First Drug Shown to Help Patients with Infantile-Onset Niemann-Pick Disease Type C Live LongerFDA approved Lembaz (adrabetadex) injection, the first treatment shown to help people with a severe form of Niemann-Pick disease type C (NPC) live longer.